SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-069741
Filing Date
2017-03-03
Accepted
2017-03-03 16:07:58
Documents
81
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d291766d10k.htm 10-K 1107986
2 EX-2.1 d291766dex21.htm EX-2.1 573980
3 EXHIBIT 12.1 d291766dex121.htm EX-12.1 26899
4 EXHIBIT 23.1 d291766dex231.htm EX-23.1 1554
5 EXHIBIT 31.1 d291766dex311.htm EX-31.1 6765
6 EXHIBIT 31.2 d291766dex312.htm EX-31.2 6804
7 EXHIBIT 32.1 d291766dex321.htm EX-32.1 3969
8 EXHIBIT 32.2 d291766dex322.htm EX-32.2 3978
9 EXHIBIT 99.1 d291766dex991.htm EX-99.1 7088
16 GRAPHIC g291766g34i14.jpg GRAPHIC 45426
17 GRAPHIC g291766g82h32.jpg GRAPHIC 74007
  Complete submission text file 0001193125-17-069741.txt   5540680

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT tkai-20161231.xml EX-101.INS 765064
11 XBRL TAXONOMY EXTENSION SCHEMA tkai-20161231.xsd EX-101.SCH 51855
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tkai-20161231_cal.xml EX-101.CAL 64893
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tkai-20161231_def.xml EX-101.DEF 175724
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE tkai-20161231_lab.xml EX-101.LAB 441587
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tkai-20161231_pre.xml EX-101.PRE 319652
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36620 | Film No.: 17663635
SIC: 2834 Pharmaceutical Preparations